This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial, Journal of Gastrointestinal and Liver Diseases, March 2018, Romanian Society of Gastroenterology and Heptatology,
DOI: 10.15403/jgld.2014.1121.271.kby.
You can read the full text:
The following have contributed to this page
